Max Delbrück Center

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (Max Delbrück Center) is one of the world’s leading biomedical research institutions. Max Delbrück, a Berlin native, was a Nobel laureate and one of the founders of molecular biology. At the locations in Berlin-Buch and Mitte, researchers from some 70 countries analyze the human system – investigating the biological foundations of life from its most elementary building blocks to systems-wide mechanisms. By understanding what regulates or disrupts the dynamic equilibrium in a cell, an organ, or the entire body, we can prevent diseases, diagnose them earlier, and stop their progression with tailored therapies. Patients should benefit as soon as possible from basic research discoveries. The Max Delbrück Center therefore supports spin-off creation and participates in collaborative networks. It works in close partnership with Charité – Universitätsmedizin Berlin in the jointly run Experimental and Clinical Research Center (ECRC), the Berlin Institute of Health (BIH) at Charité, and the German Center for Cardiovascular Research (DZHK). Founded in 1992, the Max Delbrück Center today employs 1,800 people and is funded 90 percent by the German federal government and 10 percent by the State of Berlin.

Max Delbrück Center

Robert-Rössle-Straße 10 - 13125 Berlin

Maike Sander
Maike Sander
Scientific Director

‟In an era of rapidly evolving innovation, academic institutions need to incentivize team-science, strengthen the bridge between academia and industry, and rethink research assessment. Our membership in EU-LIFE affords us a network within which to implement new approaches to academic science.“

Maike Sander, Scientific Director of the Max Delbrück Center

Facts and Figures


staff and guests


international scientists




ERC grantees